about
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional StudyCase-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screeningRisk prediction models for colorectal cancer in people with symptoms: a systematic review.Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.Fecal immunochemical test accuracy in average-risk colorectal cancer screening.Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs.Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.A Scoring System to Determine Risk of Delayed Bleeding After Endoscopic Mucosal Resection of Large Colorectal Lesions.Endoscopist characteristics that influence the quality of colonoscopy.Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.Endoscopic surveillance in patients with multiple (10-100) colorectal polyps.POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancerFaecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma.Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.Immunohistochemical alterations in invasive adenocarcinoma in endoscopically resected adenoma and factors associated with risk of residual or recurrent disease.[Purtscher's retinopathy: a rare complication of acute non-alcoholic pancreatitis][Hypertriglyceridemic acute pancreatitis. Is its clinical course different from lithiasic acute pancreatitis?].Risk of cancer in cases of suspected lynch syndrome without germline mutation.The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.Genetic susceptibility variants associated with colorectal cancer prognosis.Factors associated with intolerance after refeeding in mild acute pancreatitis.Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia.Colorectal cancer in a second round after a negative faecal immunochemical test.Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests.High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test.Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.Fecal immunochemical test accuracy in familial risk colorectal cancer screening.Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms.
P50
Q28551754-80257599-9D4C-4BBA-B672-D312CD31E837Q33983942-E1ECD4F0-FA38-4A24-916D-33EDC8BECA03Q34576842-AB461BAF-9891-459A-81F2-CFB30CA6B248Q34777582-369E07F4-26BA-4876-AC5B-2037926BDFBFQ35677316-5B05C626-763D-46D0-8DF9-67515DCD5589Q35942250-E66A638D-052B-4DCB-9491-C4569BBC2DD5Q36050809-1B4B1543-DB8A-4255-9312-7D748071F36FQ36934087-0D2E6AEC-9423-4B02-8F5E-33B737198365Q37578685-895A56BF-61D1-4E4F-B558-D682B3BFFD4FQ37698569-6A056AFF-4473-4C62-9C47-DBCB98459D92Q38841697-18F32A96-69EB-4E51-824B-EBBC8F6AA22FQ38967053-05020F74-2262-4B29-84B0-F7F4366C73F8Q39778179-56054A28-305A-473A-99D3-0852E7B7AD84Q39873538-E161793C-6BA2-448B-A7EA-07254E805B98Q40023997-429321C4-E63C-420D-88DC-380FF2F44D31Q40638799-9336A234-FA87-4904-94A4-7DCA4BE4604AQ40875173-BC3720E6-C025-415C-81A4-DF79E1E8433EQ41492470-8A7BFD46-85CD-497C-9077-6BC4509A37ABQ41593799-B9D9267D-ACBE-4D8E-B32D-3B5111C6DD84Q41839929-8914F0DB-00BB-48BF-80DF-A738A7722920Q42643188-4643BC76-86BD-4DF8-AC2D-2898854463FDQ43427213-7976D7C7-BF19-4452-9CE6-EE5C4FFB6FC9Q44189797-292BAE6E-63DC-4DE8-9643-06F08DA91E9EQ44646675-2FEFFBC4-E38F-4E72-8B4C-98205B05BF68Q44671426-0B8E31A2-8941-449B-936E-4A156EB04F81Q45145581-B5B74B15-68CE-4B1F-ABCC-820A6989CCE3Q45740719-97BBCFD1-D3AD-42F8-A849-194785E74C7CQ46414387-D2AFB772-6CCD-4D2C-891D-A3DF4DEEE0E7Q46734057-DBAACF87-8653-4F15-A132-5666399F6682Q47591483-811613C2-8D1D-4DAD-BD9E-5A8D2B4C2347Q49361827-9D477E77-7FB3-422D-89CB-3AC32ED1D712Q49615161-33FF33AF-BBFB-4C22-B16E-FA61AD42741AQ50448499-522CD9DB-A654-4C14-8EC6-CD2666BD75ECQ50475473-3EFF5D91-2E1A-4E3A-BFA2-5533DDC2A013Q50488703-5173F6AF-C119-4B80-9426-0B091CF7E665Q50489911-A642E806-5A35-4A95-AA05-AC3EBF6D2D7AQ50490585-6F253701-BB02-4397-BCDD-6556B562488BQ50730263-1B47534D-41B4-4986-A3F2-FC7D38021CAFQ50864490-F5183F1D-E77E-4630-A4A4-970551B935BAQ51034354-0484DC93-7AED-4CD9-A838-7737FE73CE8B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joaquín Cubiella
@ast
Joaquín Cubiella
@en
Joaquín Cubiella
@es
Joaquín Cubiella
@nl
type
label
Joaquín Cubiella
@ast
Joaquín Cubiella
@en
Joaquín Cubiella
@es
Joaquín Cubiella
@nl
altLabel
JOAQUIN CUBIELLA
@en
prefLabel
Joaquín Cubiella
@ast
Joaquín Cubiella
@en
Joaquín Cubiella
@es
Joaquín Cubiella
@nl
P1053
G-7692-2017
P106
P1153
6603166151
P21
P31
P496
0000-0002-9994-4831